Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases
Condition(s):Early-Stage Breast Carcinoma; Estrogen Receptor Positive TumorLast Updated:August 3, 2021Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Early-Stage Breast Carcinoma; Estrogen Receptor Positive TumorLast Updated:August 3, 2021Active, not recruiting
Condition(s):Breast CancerLast Updated:November 4, 2022Recruiting
Condition(s):Breast CancerLast Updated:August 24, 2020Completed
Condition(s):Breast CancerLast Updated:December 2, 2011Completed
Condition(s):Breast Adenocarcinoma; Hormone Receptor Positive; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIB Breast Cancer AJCC v7Last Updated:March 8, 2024Active, not recruiting
Condition(s):Early Breast CancerLast Updated:February 22, 2024Recruiting
Condition(s):Advanced Breast CancerLast Updated:March 12, 2024Terminated
Condition(s):ER+ Breast Cancer; HER2-negative Breast CancerLast Updated:August 25, 2023Recruiting
Condition(s):Breast CancerLast Updated:October 23, 2020Withdrawn
Condition(s):CancerLast Updated:August 9, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.